Chandra Bhagat Pharma Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 8.50 Cr
as on 06-07-2024
- Paid Up Capital ₹ 7.55 Cr
as on 06-07-2024
- Company Age 21 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 29.55 Cr
as on 06-07-2024
- Satisfied Charges ₹ 39.65 Cr
as on 06-07-2024
About Chandra Bhagat Pharma
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 542934.
The Corporate was formerly known as Chandra Bhagat Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.50 Cr and a paid-up capital of Rs 7.55 Cr.
The company currently has active open charges totaling ₹29.55 Cr. The company has closed loans amounting to ₹39.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Chandra Bhagat Pharma Limited India are Prachi Bhagat as CFO and Rajni Dawani as Company Secretary. Pranav Bhagat, Hemant Bhagat, Ravindra Awati, and Two other members serve as directors at the Company.
- CIN/LLPIN
L24230MH2003PLC139534
- Company No.
139534
- Stock Symbol
BSE : 542934
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Mar 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Chandra Bhagat Pharma Limited offer?
Chandra Bhagat Pharma Limited offers a wide range of products and services, including Cooking Spices and Masala, Seed Spices, Pharmaceutical Medicine, Pharmaceutical Drug, Pharmaceutical Services, Formulation Development Service, Vitamin & Multivitamin Injections, Vitamin C injection, Injectable Products, Pharmaceutical Injectables.
Who are the key members and board of directors at Chandra Bhagat Pharma?
Executive Team (3)
Hemant Bhagat
Managing DirectorAppointment Date: 10-Mar-2003
Status: Current
PB
Prachi Bhagat CFOAppointment Date: 31-Aug-2019
Status: Current
RD
Rajni Dawani Company SecretaryAppointment Date: 30-Mar-2022
Status: Current
Board Members(4)
Financial Performance and Corporate Structure Insights of Chandra Bhagat Pharma.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Chandra Bhagat Pharma?
Unlock access to Chandra Bhagat Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Jagatik Marathi Chamber Of Commerce And Industries
Active
13 years 1 month Ravindra Awati is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 Oct 2020 | ₹3.25 Cr | Open |
Axis Bank Limited Creation Date: 23 Feb 2018 | ₹24.80 Cr | Open |
Others Creation Date: 11 Sep 2017 | ₹1.50 Cr | Open |
How Many Employees Work at Chandra Bhagat Pharma?
Unlock and access historical data on people associated with Chandra Bhagat Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chandra Bhagat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chandra Bhagat Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
